TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.41 0.0 (1.21%) --- --- 0.0 (-0.19%) --- --- 0.0 (1.21%) 0.0 (1.21%)

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
-0.2124
Diluted P/E:
-0.2124
RSI(14) 1m:
40.96
VWAP:
0.41
RVol:
0.0114

Events

Period Kind Movement Occurred At
10m Price decrease 10m 0.69 -0.03 (-3.59%) Oct 15 17:38
1m Price decrease 1m 0.7 -0.01 (-2.1%) Oct 15 17:34
1m Price decrease 1m 0.72 -0.01 (-1.37%) Oct 15 17:32
1m Price increase 1m 0.74 +0.03 (+4.15%) Oct 15 17:30
10m Price increase 10m 0.74 +0.03 (+4.15%) Oct 15 17:30

Related News